China Approves Two More Home-Grown COVID-19 Antivirals

 
• By Dexter Jie Yan
  
endpoint of symptom resolution
time to symptom resolution or recovery a top pick for primary endpoint in COVID antiviral trials • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from China

More from Asia